Levofloxacin–Niflumate Salt Development as a Strategy for Improving Physicochemical Properties and Modulating Antibiotic Potency and Anti-Inflammatory Performance
Abstract
Purpose: This research aimed to develop and characterize a novel levofloxacin-niflumic acid salt, to improve its physicochemical properties, antibiotic potency, and anti-inflammatory effects. Methods: A 1:1 molar ratio salt was synthesized and its crystal structure determined using single-crystal X-ray diffractometry (SCXRD) also characterized using powder X-ray diffractometry (PXRD), differential scanning calorimetry (DSC), and Fourier transform infrared spectroscopy (FTIR). Scalability was evaluated via neat grinding, solvent-dropped grinding, hot melt mixing, and slurry techniques. Stability under controlled conditions (70-80%RH/25-30°C) was assessed using PXRD, DSC, and HPLC solubility measurements, levofloxacin's antibiotic potency (microdilution), and niflumic acid's anti-inflammatory activity (in vivo in Wistar rats) were also evaluated. Results: SCXRD confirmed the formation of a stable multicomponent salt, levofloxacin-niflumate. The slurry method successfully yielded a homogeneous powder with identical structural characteristics to the single crystal. Notably, the salt demonstrated enhanced physical and chemical stability compared to the individual drugs and their physical mixture. The solubility of niflumic acid was significantly increased, and the salt formation positively influenced both levofloxacin's antibiotic potency and niflumic acid's anti-inflammatory activity. Conclusion: The successful development of the levofloxacin-niflumate salt offers a promising…
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.